The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study

OBJECTIVES: To evaluate the role of additional chemotherapy before autologous hematopoietic cell transplantation (HCT) in patients with relapse/refractory diffuse large B‐cell lymphoma (DLBCL) who achieve partial remission following first salvage therapy. METHODS: We conducted a multicenter retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shargian, Liat, Amit, Odelia, Bernstine, Hanna, Gurion, Ronit, Gafter‐Gvili, Anat, Rozovski, Uri, Pasvolsky, Oren, Perets, Galit, Horowitz, Netanel A., Halloun, Jabour, Perry, Chava, Avivi, Irit, Raanani, Pia, Yeshurun, Moshe, Ram, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092282/
https://www.ncbi.nlm.nih.gov/pubmed/36251268
http://dx.doi.org/10.1111/ejh.13884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092282/
https://www.ncbi.nlm.nih.gov/pubmed/36251268
http://dx.doi.org/10.1111/ejh.13884

Ejemplares similares